Stratum corneum lipid processing: The final steps in barrier formation

Skin Barrier

Volumn , Issue , 2005, Pages 231-259

  Holleran, Walter M ^a   Takagi, Yutaka ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KAO CORPORATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79951580530     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (192)

1. Imokawa G, Abe A, Jin K, Higaki Y, Kawashima M, Hidano A. Decreased level of ceremides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin? J Invest Dermatol 1991; 96:523-526.
2. Melnik B, Hollmann J, Plewig G. Decreased stratum corneum ceramides in atopic individuals-a pathobiochemical factor in xerosis? [letter]. Br J Dermatol 1988; 119:547-549.
3. Motta S, Sesana S, Ghidoni R, Monti M. Content of the different lipid classes in psoriatic scale. Arch Dermatol Res 1995; 287:691-694.
4. Motta S, Monti M, Sesana S, Caputo R, Carelli S, Ghidoni R. Ceramide composition of the psoriatic scale. Biochim Biophys Acta 1993; 1182:147-151.
5. Man MM, Feingold KR, Thornfeldt CR, Elias PM. Optimization of physiological lipid mixtures for barrier repair. J Invest Dermatol 1996; 106:1096-1101.
6. Man MQ, Feingold KR, Elias PM. Exogenous lipids influence permeability barrier recovery in acetone-treated murine skin. Arch Dermatol 1993; 129:728-738.
7. Swartzendruber DC, Wertz PW, Kitko DJ, Madison KC, Downing DT. Molecular models of the intercellular lipid lamellae in mammalian stratum corneum. J Invest Dermatol 1989; 92:251-257.
8. Bouwstra JA, Cheng K, Gooris GS, Weerheim A, Ponec M. The role of ceramides 1 and 2 in the stratum corneum lipid organisation. Biochim Biophys Acta 1996; 1300:177-186.
9. Bouwstra JA, Gooris GS, Weerheim A, Kempenaar J, Ponec M. Characterization of stratum corneum structure in reconstructed epidermis by X-ray diffraction. J Lipid Res 1995; 36:496-504.
10. Elias PM, Menon GK. Structural and lipid biochemical correlates of the epidermal permeability barrier. Adv Lipid Res 1991; 24:1-26.
11. Rassner U, Feingold KR, Crumrine DA, Elias PM. Coordinate assembly of lipids and enzyme proteins into epidermal lamellar bodies. Tissue Cell 1999; 31:489-498.
12. Elias PM, Friend DS, McNutt NS. Epidermal permeability barrier: transformation of lamellar granule-disks into intercellular sheets by a membrane fusion process [letter]. J Invest Dermatol 1987; 88:459-460.
13. Futerman AH, Hannun YA. The complex life of simple sphingolipids. EMBO Rep 2004; 5:777-782.
14. Smith WL, Merrill AH Jr. Sphingolipid metabolism and signalling minireview series. J Biol Chem 2002; 277:25841-25842.
15. Wakita H, Tokura Y, Yagi H, Nishimura K, Furukawa F, Takigawa M. Keratinocyte differentiation is induced by cell-permeant ceramides and its proliferation is promoted by sphingosine. Arch Dermatol Res 1994; 286:350-354.
16. Geilen CC, Wieder T, Orfanos CE. Ceramide signalling: regulatory role in cell proliferation, differentiation and apoptosis in human epidermis. Arch Dermatol Res 1997; 289: 559-566.
17. Bektas M, Dullin Y, Wieder T, Kolter T, Sandhoff K, Brossmer R, Ihrig P, Orfanos CE, Geilen CC. Induction of apoptosis by synthetic ceramide analogues in the human keratinocyte cell line HaCaT. Exp Dermatol 1998; 7:342-349.
18. Takami Y, Abe A, Matsuda T, Shayman JA, Radin NS, Walter RJ. Effect of an inhibitor of glucosylceramide synthesis on cultured human keratinocytes. J Dermatol 1998; 25:73-77.
19. Uchida Y, Murata S, Schmuth M, Behne MJ, Lee JD, Ichikawa S, Elias PM, Hirabayashi Y, Holleran WM. Glucosylceramide synthesis and synthase expression protect against ceramide-induced stress. J Lipid Res 2002; 43:1293-1302.
20. Pettus BJ, Chalfant CE, Hannun YA. Ceramide in apoptosis: an overview and current perspectives. Biochim Biophys Acta 2002; 1585:114-125.
21. Uchida Y, Nardo AD, Collins V, Elias PM, Holleran WM. De novo ceramide synthesis participates in the ultraviolet B irradiation-induced apoptosis in undifferentiated cultured human keratinocytes. J Invest Dermatol 2003; 120:662-669.
22. Braun PE, Morell P, Radin NS. Synthesis of C18-dihydrosphingosines and C20-dihydrosphingosines, ketodihydrosphingosines, and ceramides by microsomal preparations from mouse brain. J Biol Chem 1970; 245:335-341.
23. Williams RD, Wang E, Merrill AH Jr. Enzymology of long-chain base synthesis by liver: characterization of serine palmitoyltransferase in rat liver microsomes. Arch Biochem Biophys 1984; 228:282-291.
24. Holleran WM, Williams ML, Gao WN, Elias PM. Serine-palmitoyl transferase activity in cultured human keratinocytes. J Lipid Res 1990; 31:1655-1661.
25. Merrill AH Jr, Wang E. Biosynthesis of long-chain (sphingoid) bases from serine by LM cells. Evidence for introduction of the 4-trans-double bond after de novo biosynthesis of N-acylsphinganine(s). J Biol Chem 1986; 261:3764-3769.
26. Michel C, van Echten-Deckert G, Rother J, Sandhoff K, Wang E, Merrill AH Jr. Characterization of ceramide synthesis. A dihydroceramide desaturase introduces the 4,5-trans-double bond of sphingosine at the level of dihydroceramide. J Biol Chem 1997; 272:22432-22437.
27. Holleran WM, Gao WN, Feingold KR, Elias PM. Localization of epidermal sphingo-lipid synthesis and serine palmitoyl transferase activity: alterations imposed by permeability barrier requirements. Arch Dermatol Res 1995; 287:254-258.
28. Gray GM, Yardley HJ. Different populations of pig epidermal cells: isolation and lipid composition. J Lipid Res 1975; 16:441-447.
29. Elias PM, Brown BE, Fritsch P, Goerke J, Gray GM, White RJ. Localization and composition of lipids in neonatal mouse stratum granulosum and stratum corneum. J Invest Dermatol 1979; 73:339-348.
30. Lampe MA, Williams ML, Elias PM. Human epidermal lipids: characterization and modulations during differentiation. J Lipid Res 1983; 24:131-140.
31. Holleran WM, Feingold KR, Man MQ, Gao WN, Lee JM, Elias PM. Regulation of epidermal sphingolipid synthesis by permeability barrier function. J Lipid Res 1991; 32:1151-1158.
32. Harris IR, Farrell AM, Grunfeld C, Holleran WM, Elias PM, Feingold KR. Permeability barrier disruption coordinately regulates mRNA levels for key enzymes of cholesterol, fatty acid, and ceramide synthesis in the epidermis. J Invest Dermatol 1997; 109:783-787.
33. Stachowitz S, Alessandrini F, Abeck D, Ring J, Behrendt H. Permeability barrier disruption increases the level of serine palmitoyltransferase in human epidermis. J Invest Dermatol 2002; 119:1048-1052.
34. Holleran WM, Man MQ, Gao WN, Menon GK, Elias PM, Feingold KR. Sphingolipids are required for mammalian epidermal barrier function. Inhibition of sphingolipid synthesis delays barrier recovery after acute perturbation. J Clin Invest 1991; 88:1338-1345.
35. Basu S, Kaufman B, Roseman S. Enzymatic synthesis of ceramide-glucose and ceramide-lactose by glycosyltransferases from embryonic chicken brain. J Biol Chem 1968; 243:5802-5804.
36. Ichikawa S, Sakiyama H, Suzuki G, Hidari KI, Hirabayashi Y. Expression cloning of a cDNA for human ceramide glucosyltransferase that catalyzes the first glycosylation step of glycosphingolipid synthesis. Proc Natl Acad Sci USA 1996; 93:12654.
37. Yamaoka S, Miyaji M, Kitano T, Umehara H, Okazaki T. Expression cloning of a human cDNA restoring sphingomyelin synthesis and cell growth in sphingomyelin synthase-defective lymphoid cells. J Biol Chem 2004; 279:18688-18693.
38. Huitema K, van den Dikkenberg J, Brouwers JF, Holthuis JC. Identification of a family of animal sphingomyelin synthases. EMBO J 2004; 23:33-44.
39. Wertz PW, Downing DT, Freinkel RK, Traczyk TN. Sphingolipids of the stratum corneum and lamellar granules of fetal rat epidermis. J Invest Dermatol 1984; 83: 193-195.
40. Grayson S, Johnson-Winegar AG, Wintroub BU, Isseroff RR, Epstein EH Jr, Elias PM. Lamellar body-enriched fractions from neonatal mice: preparative techniques and partial characterization. J Invest Dermatol 1985; 85:289-294.
41. Freinkel RK, Traczyk TN. Lipid composition and acid hydrolase content of lamellar granules of fetal rat epidermis. J Invest Dermatol 1985; 85:295-298.
42. Hamanaka S, Nakazawa S, Yamanaka M, Uchida Y, Otsuka F. Glucosylceramide accumulates preferentially in lamellar bodies in differentiated keratinocytes. Br J Dermatol 2005; 152:426-434.
43. Madison KC, Sando GN, Howard EJ, True CA, Gilbert D, Swartzendruber DC, Wertz PW. Lamellar granule biogenesis: a role for ceramide glucosyltransferase, lysosomal enzyme tansport, and the golgi. J Invest Dermatol Symp Proc 1998; 3:80-86.
44. Sando GN, Howard EJ, Madison KC. Induction of ceramide glucosyltransferase activity in cultured human keratinocytes. Correlation with culture differentiation. J Biol Chem 1996; 271:22044-22051.
45. Watanabe R, Wu K, Paul P, Marks DL, Kobayashi T, Pittelkow MR, Pagano RE. Up-regulation of glucosylceramide synthase expression and activity during human keratinocyte differentiation. J Biol Chem 1998; 273:9651-9655.
46. Chujor CS, Feingold KR, Elias PM, Holleran WM. Glucosylceramide synthase activity in murine epidermis: quantitation, localization, regulation, and requirement for barrier homeostasis. J Lipid Res 1998; 39:277-285.
47. Hanley K, Jiang Y, Holleran WM, Elias PM, Williams ML, Feingold KR. Glucosylceramide metabolism is regulated during normal and hormonally stimulated epidermal barrier development in the rat. J Lipid Res 1997; 38:576-584.
48. Wertz PW, Downing DT. Ceramides of pig epidermis: structure determination. J Lipid Res 1983; 24:759-765.
49. Robson KJ, Stewart ME, Michelsen S, Lazo ND, Downing DT. 6-Hydroxy-4-sphingenine in human epidermal ceramides. J Lipid Res 1994; 35:2060-2068.
50. Stewart ME, Downing DT. A new 6-hydroxy-4-sphingenine-containing ceramide in human skin. J Lipid Res 1999; 40:1434-1439.
51. Ponec M, Weerheim A, Lankhorst P, Wertz P. New acylceramide in native and reconstructed epidermis. J Invest Dermatol 2003; 120:581-588.
52. Uchida Y, Hara M, Nishio H, Sidransky E, Inoue S, Otsuka F, Suzuki A, Elias PM, Holleran WM, Hamanaka S. Epidermal sphingomyelins are precursors for selected stratum corneum ceramides. J Lipid Res 2000; 41:2071-2082.
53. Hamanaka S, Hara M, Nishio H, Otsuka F, Suzuki A, Uchida Y. Human epidermal glucosylceramides are major precursors of stratum corneum ceramides. J Invest Dermatol 2002; 119:416-423.
54. Cox P, Squier CA. Variations in lipids in different layers of porcine epidermis. J Invest Dermatol 1986; 87:741-744.
55. Vielhaber G, Pfeiffer S, Brade L, Lindner B, Goldmann T, Vollmer E, Hintze U, Wittern KP, Wepf R. Localization of ceramide and glucosylceramide in human epidermis by immunogold electron microscopy. J Invest Dermatol 2001; 117:1126-1136.
56. Ockerman PA. Acid hydrolases in human skin. Acta Derm Venereol 1969; 49:139-141.
57. Goldberg MF, Cotlier E, Fichenscher LG, Kenyon K, Enat R, Borowsky SA. Macular cherry-red spot, corneal clouding, and -galactosidase deficiency. Clinical, biochemical, and electron microscopic study of a new autosomal recessive storage disease. Arch Intern Med 1971; 128:387-398.
58. Ohkawara A, Halprin K, Taylor J, Levine V. Acid hydrolases in the human epidermis. Br J Dermatol 1972; 83450-83459:450-459.
59. Mier PD, van den Hurk JJ. Lysosomal hydrolases ofthe epidermis. I. Glycosidases. Br J Dermatol 1975; 93:1-10.
60. Wolff K, Schreiner E. Epidermal lysosomes. Electron microscopic-cytochemical studies. Arch Dermatol 1970; 101:276-286.
61. Nemanic MK, Whitehead JS, Elias PM. Alterations in membrane sugars during epidermal differentiation: visualization with lectins and role of glycosidases. J Histochem Cytochem 1983; 31:887-897.
62. Wertz PW, Downing DT. Beta-glucosidase activity in porcine epidermis. Biochim Biophys Acta 1989; 1001:115-119.
63. Chang F, Wertz PW, Squier CA. Comparison of glycosidase activities in epidermis, palatal epithelium and buccal epithelium. Comp Biochem Physiol B 1991; 100:137-139.
64. Squier CA, Cox P, Wertz PW. Lipid content and water permeability of skin and oral mucosa. J Invest Dermatol 1991; 96:123-126.
65. Squier CA, Wertz PW, Cox P. Thin-layer chromatographic analyses of lipids in different layers of porcine epidermis and oral epithelium. Arch Oral Biol 1991; 36:647-653.
66. Lesch CA, Squier CA, Cruchley A, Williams DM, Speight P. The permeability of human oral mucosa and skin to water. J Dent Res 1989; 68:1345-1349.
67. Holleran WM, Takagi Y, Imokawa G, Jackson S, Lee JM, Elias PM. Beta-Glucocerebrosidase activity in murine epidermis: characterization and localization in relation to differentiation. J Lipid Res 1992; 33:1201-1209.
68. Takagi Y, Kriehuber E, Imokawa G, Elias PM, Holleran WM. Beta-glucocerebrosidase activity in mammalian stratum corneum. J Lipid Res 1999; 40:861-869.
69. Chang F, Wertz PW, Squier CA. Localization of beta-glucosidase activity within keratinizing epithelia. Comp Biochem Physiol Comp Physiol 1993; 105:251-253.
70. Mauro T, Holleran WM, Grayson S, Gao WN, Man MQ, Kriehuber E, Behne M, Feingold KR, Elias PM. Barrier recovery is impeded at neutral pH, independent of ionic effects: implications for extracellular lipid processing. Arch Dermatol Res 1998; 290:215-222.
71. Fluhr JW, Mao-Qiang M, Brown BE, Hachem JP, Moskowitz DG, Demerjian M, Haftek M, Serre G, Crumrine D, Mauro TM, Elias PM, Feingold KR. Functional consequences of a neutral pH in neonatal rat stratum corneum. J Invest Dermatol 2004; 123:140-151.
72. Holleran WM, Takagi Y, Menon GK, Jackson SM, Lee JM, Feingold KR, Elias PM. Permeability barrier requirements regulate epidermal beta-glucocerebrosidase. J Lipid Res 1994; 35:905-912.
73. Legler G, Bieberich E. Active site directed inhibition of a cytosolic beta-glucosidase from calf liver by bromoconduritol B epoxide and bromoconduritol F. Arch Biochem Biophys 1988; 260:437-442.
74. Holleran WM, Takagi Y, Menon GK, Legler G, Feingold KR, Elias PM. Processing of epidermal glucosylceramides is required for optimal mammalian cutaneous permeability barrier function. J Clin Invest 1993; 91:1656-1664.
75. Holleran WM, Ginns EI, Menon GK, Grundmann JU, Fartasch M, McKinney CE, Elias PM, Sidransky E. Consequences of beta-glucocerebrosidase deficiency in epidermis. Ultrastructure and permeability barrier alterations in Gaucher disease. J Clin Invest 1994; 93:1756-1764.
76. Tybulewicz VL, Tremblay ML, LaMarca ME, Willemsen R, Stubblefield BK, Winfield S, Zablocka B, Sidransky E, Martin BM, Huang SP, et al. Animal model of Gaucher's disease from targeted disruption of the mouse glucocerebrosidase gene. Nature 1992; 357:407-410.
77. Sidransky E, Sherer DM, Ginns EI. Gaucher disease in the neonate: a distinct Gaucher phenotype is analogous to a mouse model created by targeted disruption of the glucocerebrosidase gene. Pediatr Res 1992; 32:494-498.
78. Barranger JA, Ginns EI, Glucosylceramide lipidoses: Gaucher disease. In: Scriver CR, et al. eds. Metabolic Basis of Inherited Disease. New York: McGraw-Hill, 1989: 1677-1698.
79. Sidransky E, Fartasch M, Lee RE, Metlay LA, Abella S, Zimran A, Gao W, Elias PM, Ginns EI, Holleran WM. Epidermal abnormalities may distinguish type 2 from type 1 and type 3 of Gaucher disease. Pediatr Res 1996; 39:134-141.
80. Liu Y, Suzuki K, Reed JD, Grinberg A, Westphal H, Hoffmann A, Doring T, Sandhoff K, Proia RL. Mice with types 2 and 3 Gaucher disease point mutations generated by a single insertion mutagenesis procedure. Proc Natl Acad Sci USA 1998; 95:2503-2508.
81. Wertz PW, Cox PS, Squier CA, Downing DT. Lipids of epidermis and keratinized and non-keratinized oral epithelia. Comp Biochem Physiol B 1986; 83:529-531.
82. Elias PM, Menon GK, Grayson S, Brown BE, Rehfeld SJ. Avian sebokeratocytes and marine mammal lipokeratinocytes: structural, lipid biochemical, and functional considerations. Am J Anat 1987; 180:161-177.
83. Hachem JP, Crumrine D, Fluhr J, Brown BE, Feingold KR, Elias PM. pH directly regulates epidermal permeability barrier homeostasis stratum corneum integrity/cohesion. J Invest Dermatol 2003; 121:345-353.
84. Behne MJ, Meyer J, Hanson KM, Barry NP, Murata S, Crumrine D, Clegg RR, Gratton E, Holleran WM, Elias PM, Mauro TM. NHE1 regulates the stratum corneum permeability barrier homeostasis: microenvironment acidifcation assessed with FLIM. J Biol Chem 2002; 277:47399-406.
85. Redoules D, Tarroux R, Assalit MF, Peri JJ. Characterisation and assay of five enzymatic activities in the stratum corneum using tape-strippings. Skin Pharmacol Appl Skin Physiol 1999; 12:182-192.
86. Hachem JP, Man MQ, Crumrine D, Uchida Y, Brown BE, Rogiers V, Roseeuw D, Feingold KR, Elias PM. Sustained serine protease activity by prolonged increase in pH leads to degradation of lipid processing enzymes and profound alterations of barrier function and stratum corneum integrity. J Invest Dermatol. 2005. In press.
87. O'Brien JS, Kishimoto Y. Saposin proteins: structure, function, and role in human lysosomal storage disorders. FASEB J 1991; 5:301-308.
88. Morimoto S, Martin BM, Yamamoto Y, Kretz KA, O'Brien JS, Kishimoto Y. Saposin A: second cerebrosidase activator protein. Proc Natl Acad Sci USA 1989; 86:3389-3393.
89. Morimoto S, Kishimoto Y, Tomich J, Weiler S, Ohashi T, Barranger JA, Kretz KA, O'Brien JS. Interaction of saposins, acidic lipids, and glucosylceramidase. J Biol Chem 1990; 265:1933-1937.
90. Hiraiwa M, O'Brien JS, Kishimoto Y, Galdzicka M, Fluharty AL, Ginns EI, Martin BM. Isolation, characterization, and proteolysis of human prosaposin, the precursor of saposins (sphingolipid activator proteins). Arch Biochem Biophys 1993; 304:110-116.
91. Doering T, Holleran WM, Potratz A, Vielhaber G, Elias PM, Suzuki K, Sandhoff K. Sphingolipid activator proteins are required for epidermal permeability barrier formation. J Biol Chem 1999; 274:11038-11045.
92. Cui CY, Kusuda S, Seguchi T, Takahashi M, Aisu K, Tezuka T. Decreased level of prosaposin in atopic skin. J Invest Dermatol 1997; 109:319-323.
93. Jensen JM, Folster-Holst R, Baranowsky A, Schunck M, Winoto-Morbach S, Neumann C, Schutze S, Proksch E. Impaired sphingomyelinase activity and epidermal differentiation in atopic dermatitis. J Invest Dermatol 2004; 122:1423-1431.
94. Wertz PW, Downing DT. Covalent attachment of omega-hydroxyacid derivatives to epidermal macromolecules: a preliminary characterization. Biochem Biophys Res Commun 1986; 137:992-997.
95. Wertz PW, Downing DT. Covalently bound omega-hydroxyacylsphingosine in the stratum corneum. Biochim Biophys Acta 1987; 917:108-111.
96. Wertz PW, Madison KC, Downing DT. Covalently bound lipids of human stratum corneum. J Invest Dermatol 1989; 92:109-111.
97. Behne M, Uchida Y, Seki T, de Montellano PO, Elias PM, Holleran WM. Omegahydroxyceramides are required for corneocyte lipid envelope (CLE) formation and normal epidermal permeability barrier function. J Invest Dermatol 2000; 114:185-192.
98. Stewart ME, Downing DT. The omega-hydroxyceramides ofpig epidermis are attached to corneocytes solely through omega-hydroxyl groups. J Lipid Res 2001; 42:1105-1110.
99. Marekov LN, Steinert PM. Ceramides are bound to structural proteins of the human foreskin epidermal cornified cell envelope. J Biol Chem 1998; 273:17763-17770.
100. Nemes Z, Marekov LN, Fésüs L, Steinert PM. A novel function for transglutaminase 1: attachment of long-chain omega-hydroxyceramides to involucrin by ester bond formation. Proc Natl Acad Sci USA 1999; 96:8402-8407.
101. Elias PM, Schmuth M, Uchida Y, Rice RH, Behne M, Crumrine D, Feingold KR, Holleran WM, Pharm D. Basis for the permeability barrier abnormality in lamellar ichthyosis. Exp Dermatol 2002; 11:248-256.
102. Paige DG, Morse-Fisher N, Harper JI. Quantification of stratum corneum ceramides and lipid envelope ceramides in the hereditary ichthyoses. Br J Dermatol 1994; 131:23-27.
103. Doering T, Proia RL, Sandhoff K. Accumulation of protein-bound epidermal glucosylceramides in beta-glucocerebrosidase deficient type-2 Gaucher mice. FEBS Lett 1999; 447:167-170.
104. Meguro S, Arai Y, Masukawa Y, Uie K, Tokimitsu I. Relationship between covalently bound ceramides and transepidermal water loss (TEWL). Arch Dermatol Res 2000; 292:463-468.
105. Hou SY, Mitra AK, White SH, Menon GK, Ghadially R, Elias PM. Membrane structures in normal and essential fatty acid-deficient stratum corneum: characterization by ruthenium tetroxide staining and x-ray diffraction. J Invest Dermatol 1991; 96:215-223.
106. Russell LJ, DiGiovanna JJ, Rogers GR, Steinert PM, Hashem N, Compton JG, Bale SJ. Mutations in the gene for transglutaminase 1 in autosomal recessive lamellar ichthyosis. Nat Genet 1995; 9:279-283.
107. Huber M, Rettler I, Bernasconi K, Frenk E, Lavrijsen SP, Ponec M, Bon A, Lautenschlager S, Schorderet DF, Hohl D. Mutations of keratinocyte transglutaminase in lamellar ichthyosis [see comments]. Science 1995; 267:525-528.
108. Bowser PA, Gray GM. Sphingomyelinase in pig and human epidermis. J Invest Dermatol 1978; 70:331-335.
109. Schmuth M, Man MQ, Weber F, Gao W, Feingold KR, Fritsch P, Elias PM, Holleran WM. Permeability barrier disorder in Niemann-Pick disease: sphingomyelin-ceramide processing required for normal barrier homeostasis. J Invest Dermatol 2000; 115:459-466.
110. Jensen JM, Schütze S, Forl M, Kronke M, Proksch E. Roles for tumor necrosis factor receptor p55 and sphingomyelinase in repairing the cutaneous permeability barrier. J Clin Invest 1999; 104:1761-1770.
111. Menon GK, Grayson S, Elias PM. Cytochemical and biochemical localization of lipase and sphingomyelinase activity in mammalian epidermis. J Invest Dermatol 1986; 86:591-597.
112. Maloney ME, Williams ML, Epstein EH Jr, Law MY, Fritsch PO, Elias PM. Lipids in the pathogenesis of ichthyosis: topical cholesterol sulfate-induced scaling in hairless mice. J Invest Dermatol 1984; 83:252-256.
113. Zettersten E, Man MQ, Sato J, Denda M, Farrell A, Ghadially R, Williams ML, Feingold KR, Elias PM. Recessive x-linked ichthyosis: role of cholesterol-sulfate accumulation in the barrier abnormality. J Invest Dermatol 1998; 111:784-790.
114. Kreder D, Krut O, Adam-Klages S, Wiegmann K, Scherer G, Plitz T, Jensen JM, Proksch E, Steinmann J, Pfeffer K, Kronke M. Impaired neutral sphingomyelinase activation and cutaneous barrier repair in FAN-deficient mice. EMBO J 1999; 18:2472-2479.
115. Yamamura T, Tezuka T. Change in sphingomyelinase activity in human epidermis during aging. J Dermatol Sci 1990; 1:79-83.
116. Ghadially R, Brown BE, Sequeira-Martin SM, Feingold KR, Elias PM. The aged epidermal permeability barrier. Structural, functional, and lipid biochemical abnormalities in humans and a senescent murine model. J Clin Invest 1995; 95:2281-2290.
117. Mao-Qiang M, Feingold KR, Jain M, Elias PM. Extracellular processing of phospholipids is required for permeability barrier homeostasis. J Lipid Res 1995; 36:1925-1935.
118. Mao-Qiang M, Jain M, Feingold KR, Elias PM. Secretory phospholipase A2 activity is required for permeability barrier homeostasis. J Invest Dermatol 1996; 106:57-63.
119. Haas U, Podda M, Behne M, Gurrieri S, Alonso A, Furstenberger G, Pfeilschifter J, Lambeau G, Gelb MH, Kaszkin M. Characterization and differentiation-dependent regulation of secreted phospholipases A in human keratinocytes and in healthy and psoriatic human skin. J Invest Dermatol 2005; 124:204-211.
120. Fluhr JW, Kao J, Jain M, Ahn SK, Feingold KR, Elias PM. Generation of free fatty acids from phospholipids regulates stratum corneum acidification and integrity. J Invest Dermatol 2001; 117:44-51.
121. Cuvillier O, Pirianov G, Kleuser B, Vanek PG, Coso OA, Gutkind S, Spiegel S. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 1996; 381:800-803.
122. Cuvillier O, Rosenthal DS, Smulson ME, Spiegel S. Sphingosine 1-phosphate inhibits activation of caspases that cleave poly(ADP-ribose) polymerase and lamins during Fas-mediated and ceramide-mediated apoptosis in Jurkat T lymphocytes. J Biol Chem 1998; 273:2910-2916.
123. Vogler R, Sauer B, Kim DS, Schafer-Korting M, Kleuser B. Sphingosine-1-phosphate and its potentially paradoxical effects on critical parameters of cutaneous wound healing. J Invest Dermatol 2003; 120:693-700.
124. Sauer B, Vogler R, von Wenckstern H, Fujii M, Anzano MB, Glick AB, SchaferKorting M, Roberts AB, Kleuser B. Involvement of Smad signalling in sphingosine 1-phosphate-mediated biological responses of keratinocytes. J Biol Chem 2004; 279: 38471-38479.
125. El Bawab S, Roddy P, Qian T, Bielawska A, Lemasters JJ, Hannun YA. Molecular cloning and characterization of a human mitochondrial ceramidase. J Biol Chem 2000; 275:21508-21513.
126. El Bawab S, Bielawska A, Hannun YA. Purification and characterization of a membrane-bound nonlysosomal ceramidase from rat brain. J Biol Chem 1999; 274:27948-27955.
127. Mitsutake S, Tani M, Okino N, Mori K, Ichinose S, Omori A, Iida H, Nakamura T, Ito M. Purification, characterization, molecular cloning, and subcellular distribution of neutral ceramidase of rat kidney. J Biol Chem 2001; 276:26249-26259.
128. Koch J, Gartner S, Li CM, Quintern LE, Bernardo K, Levran O, Schnabel D, Desnick RJ, Schuchman EH, Sandhoff K. Molecular cloning and characterization of a full-length complementary DNA encoding human acid ceramidase. Identification of the first molecular lesion causing Farber disease. J Biol Chem 1996; 271:33110-33115.
129. Bernardo K, Hurwitz R, Zenk T, Desnick RJ, Ferlinz K, Schuchman EH, Sandhoff K. Purification, characterization, and biosynthesis of human acid ceramidase. J Biol Chem 1995; 270:11098-11102.
130. Mao C, Xu R, Szulc ZM, Bielawska A, Galadari SH, Obeid LM. Cloning and characterization of a novel human alkaline ceramidase. A mammalian enzyme that hydrolyzes phytoceramide. J Biol Chem 2001; 276:26577-26588.
131. Mao C, Xu R, Szulc ZM, Bielawski J, Becker KP, Bielawska A, Galadari SH, Hu W, Obeid LM. Cloning and characterization of a mouse endoplasmic reticulum alkaline ceramidase: an enzyme that preferentially regulates metabolism of very long chain ceramides. J Biol Chem 2003; 278:31184-31191.
132. Dulaney J, Moser HW, Sidbury J, Milunsky A. The biochemical defect in Farber's disease. Adv Exp Med Biol 1976; 68:403-411.
133. Dulaney JT, Milunsky A, Sidbury JB, Hobolth N, Moser HW. Diagnosis of lipogranulomatosis (Farber disease) by use of cultured fibroblasts. J Pediatr 1976; 89:59-61.
134. Abenoza P, Sibley RK. Farber's disease: a fine structural study. Ultrastruct Pathol 1987; 11:397-403.
135. Li CM, Park JH, Simonaro CM, He X, Gordon RE, Friedman AH, Ehleiter D, Paris F, Manova K, Hepbildikler S, Fuks Z, Sandhoff K, Kolesnick R, Schuchman EH. Insertional mutagenesis of the mouse acid ceramidase gene leads to early embryonic lethality in homozygotes and progressive lipid storage disease in heterozygotes. Genomics 2002; 79:218-224.
136. Tani M, Okino N, Sueyoshi N, Ito M. Conserved amino acid residues in the COOH-terminal tail are indispensable for the correct folding and localization and enzyme activity of neutral ceramidase. J Biol Chem 2004; 279:29351-29358.
137. Tani M, Iida H, Ito M. O-glycosylation of mucin-like domain retains the neutral ceramidase on the plasma membranes as a type II integral membrane protein. J Biol Chem 2003; 278:10523-10530.
138. Choi MS, Anderson MA, Zhang Z, Zimonjic DB, Popescu N, Mukherjee AB. Neutral ceramidase gene: role in regulating ceramide-induced apoptosis. Gene 2003; 315: 113-122.
139. Wertz PW, Downing DT. Ceramidase activity in porcine epidermis. FEBS Lett 1990; 268:110-112.
140. Wertz PW, Downing DT. Free sphingosine in human epidermis. J Invest Dermatol 1990; 94:159-161.
141. Wertz PW, Downing DT. Free sphingosines in porcine epidermis. Biochim Biophys Acta 1989; 1002:213-217.
142. Long SA, Wertz PW, Strauss JS, Downing DT. Human stratum corneum polar lipids and desquamation. Arch Dermatol Res 1985; 277:284-287.
143. Weerheim A, Ponec M. Determination of stratum corneum lipid profile by tape stripping in combination with high-performance thin-layer chromatography. Arch Dermatol Res 2001; 293:191-199.
144. Yada Y, Higuchi K, Imokawa G. Purification and biochemical characterization of membrane-bound epidermal ceramidases from guinea pig skin. J Biol Chem 1995; 270:12677-12684.
145. Houben E, Uchida Y, Mao C, Obeid LM, Elias PM, Holleran WM. Differentiationdependent expression of ceramidase isoforms in human keratinocytes and epidermis. J Invest Dermatol 2004; 122:76a.
146. Elias PM, Williams ML, Maloney ME, Bonifas JA, Brown BE, Grayson S, Epstein EH Jr. Stratum corneum lipids in disorders of cornification. Steroid sulfatase and cholesterol sulfate in normal desquamation and the pathogenesis of recessive X-linked ichthyosis. J Clin Invest 1984; 74:1414-1421.
147. Elias PM, Crumrine D, Rassner U, Hachem JP, Menon GK, Man W, Choy MH, Leypoldt L, Feingold KR, Williams ML. Basis for abnormal desquamation and permeability barrier dysfunction in RXLI. J Invest Dermatol 2004; 122:314-319.
148. Marinkovic-Ilsen A, Koppe JG, Jobsis AC, de Groot WP. Enzymatic basis of typical X-linked ichthyosis. Lancet 1978; 2:1097.
149. Koppe G, Marinkovic-Ilsen A, Rijken Y, De Groot WP, Jobsis AC. X-linked icthyosis. A sulphatase deficiency. Arch Dis Child 1978; 53:803-806.
150. Webster D, France JT, Shapiro LJ, Weiss R. X-linked ichthyosis due to steroid-sulphatase deficiency. Lancet 1978; 1:70-72.
151. Williams ML, Elias PM. Stratum corneum lipids in disorders of cornification: increased cholesterol sulfate content of stratum corneum in recessive x-linked ichthyosis. J Clin Invest 1981; 68:1404-1410.
152. Rehfeld SJ, Williams ML, Elias PM. Interactions of cholesterol and cholesterol sulfate with free fatty acids: possible relevance for the pathogenesis of recessive X-linked ichthyosis. Arch Dermatol Res 1986; 278:259-263.
153. McIntosh TJ. Organization of skin stratum corneum extracellular lamellae: diffraction evidence for asymmetric distribution of cholesterol. Biophys J 2003; 85:1675-1681.
154. Williams ML. Lipids in normal and pathological desquamation. Adv Lipid Res 1991; 24:211-262.
155. Hanley K, Wood L, Ng DC, He SS, Lau P, Moser A, Elias PM, Bikle DD, Williams ML, Feingold KR. Cholesterol sulfate stimulates involucrin transcription in keratinocytes by increasing Fra-1, Fra-2, and Jun D. J Lipid Res 2001; 42:390-398.
156. Denning MF, Kazanietz MG, Blumberg PM, Yuspa SH. Cholesterol sulfate activates multiple protein kinase C isoenzymes and induces granular cell differentiation in cultured murine keratinocytes. Cell Growth Differ 1995; 6:1619-1626.
157. Di Nardo A, Wertz P, Giannetti A, Seidenari S. Ceramide and cholesterol composition of the skin of patients with atopic dermatitis. Acta Derm Venereol 1998; 78:27-30.
158. Melnik B, Hollmann J, Hofmann U, Yuh MS, Plewig G. Lipid composition of outer stratum corneum and nails in atopic and control subjects. Arch Dermatol Res 1990; 282:549-551.
159. Yamamoto A, Serizawa S, Ito M, Sato Y. Stratum corneum lipid abnormalities in atopic dermatitis. Arch Dermatol Res 1991; 283:219-223.
160. Jin K, Higaki Y, Takagi Y, Higuchi K, Yada Y, Kawashima M, Imokawa G. Analysis of beta-glucocerebrosidase and ceramidase activities in atopic and aged dry skin. Acta Derm Venereol 1994; 74:337-340.
161. Murata Y, Ogata J, Higaki Y, Kawashima M, Yada Y, Higuchi K, Tsuchiya T, Kawainami S, Imokawa G. Abnormal expression of sphingomyelin acylase in atopic dermatitis: an etiologic factor for ceramide deficiency? J Invest Dermatol 1996; 106: 1242-1249.
162. Hara J, Higuchi K, Okamoto R, Kawashima M, Imokawa G. High-expression of sphingomyelin deacylase is an important determinant of ceramide deficiency leading to barrier disruption in atopic dermatitis. J Invest Dermatol 2000; 115:406-413.
163. Okamoto R, Arikawa J, Ishibashi M, Kawashima M, Takagi Y, Imokawa G. Sphingosylphosphorylcholine is upregulated in the stratum corneum of patients with atopic dermatitis. J Lipid Res 2003; 44:93-102.
164. Ishibashi M, Arikawa J, Okamoto R, Kawashima M, Takagi Y, Ohguchi K, Imokawa G. Abnormal expression of the novel epidermal enzyme, glucosylceramide deacylase, and the accumulation of its enzymatic reaction product, glucosylsphingosine, in the skin of patients with atopic dermatitis. Lab Invest 2003; 83:397-408.
165. Higuchi K, Hara J, Okamoto R, Kawashima M, Imokawa G. The skin of atopic dermatitis patients contains a novel enzyme, glucosylceramide sphingomyelin deacylase, which cleaves the N-acyl linkage of sphingomyelin and glucosylceramide. Biochem J 2000; 350(Pt 3):747-756.
166. Arikawa J, Ishibashi M, Kawashima M, Takagi Y, Ichikawa Y, Imokawa G. Decreased levels of sphingosine, a natural antimicrobial agent, may be associated with vulnerability of the stratum corneum from patients with atopic dermatitis to colonization by Staphylococcus aureus. J Invest Dermatol 2002; 119:433-439.
167. Imokawa G, Takagi Y, Higuchi K, Kondo H, Yada Y. Sphingosylphosphorylcholine is a potent inducer of intercellular adhesion molecule-1 expression in human keratinocytes. J Invest Dermatol 1999; 112:91-96.
168. Higuchi K, Kawashima M, Takagi Y, Kondo H, Yada Y, Ichikawa Y, Imokawa G. Sphingosylphosphorylcholine is an activator of transglutaminase activity in human keratinocytes. J Lipid Res 2001; 42:1562-1570.
169. Macheleidt O, Kaiser HW, Sandhoff K. Deficiency of epidermal protein-bound omega-hydroxyceramides in atopic dermatitis. J Invest Dermatol 2002; 119:166-173.
170. Okino N, Ichinose S, Omori A, Imayama S, Nakamura T, Ito M. Molecular cloning, sequencing, and expression of the gene encoding alkaline ceramidase from Pseudomonas aeruginosa. Cloning of a ceramidase homologue from Mycobacterium tuberculosis. J Biol Chem 1999; 274:36616-36622.
171. Ohnishi Y, Okino N, Ito M, Imayama S. Ceramidase activity in bacterial skin flora as a possible cause of ceramide deficiency in atopic dermatitis. Clin Diagn Lab Immunol 1999; 6:101-104.
172. Okino N, Tani M, Imayama S, Ito M. Purification and characterization of a novel ceramidase from Pseudomonas aeruginosa. J Biol Chem 1998; 273:14368-14373.
173. Miller SJ, Aly R, Shinefeld HR, Elias PM. In vitro and in vivo antistaphylococcal activity of human stratum corneum lipids. Arch Dermatol 1988; 124:209-215.
174. Kusuda S, Cui CY, Takahashi M, Tezuka T. Localization of sphingomyelinase in lesional skin of atopic dermatitis patients. J Invest Dermatol 1998; 111:733-738.
175. Fartasch M, Diepgen TL. The barrier function in atopic dry skin. Disturbance of membrane-coating granule exocytosis and formation of epidermal lipids? Acta Derm Venereol Suppl 1992; 176:26-31.
176. Fartasch M. Epidermal barrier in disorders of the skin. Microsc Res Tech 1997; 38: 361-372.
177. Proksch E, Jensen JM, Elias PM. Skin lipids and epidermal differentiation in atopic dermatitis. Clin Dermatol 2003; 21:134-144.
178. Motta S, Monti M, Sesana S, Mellesi L, Ghidoni R, Caputo R. Abnormality of water barrier function in psoriasis. Role of ceramide fractions. Arch Dermatol 1994; 130: 452-456.
179. Mier PD, van den Hurk JJ. Acid hydrolases in psoriatic epidermis. Br J Dermatol 1976; 94:219-220.
180. Mier PD, van den Hurk JJ. Lysosomal hydrolases of the epidermis. 6. Changes in disease. Br J Dermatol 1976; 95:271-274.
181. Alessandrini F, Pfister S, Kremmer E, Gerber JK, Ring J, Behrendt H. Alterations of glucosylceramide-beta-glucosidase levels in the skin of patients with psoriasis vulgaris. J Invest Dermatol 2004; 123:1030-1036.
182. Alessandrini F, Stachowitz S, Ring J, Behrendt H. The level of prosaposin is decreased in the skin of patients with psoriasis vulgaris. J Invest Dermatol 2001; 116:394-400.
183. Ho MW, O'Brien JS. Gaucher's disease: deficiency of 'acid'-glucosidase and reconstitution of enzyme activity in vitro. Proc Natl Acad Sci USA 1971; 68:2810-2813.
184. Wilkening G, Linke T, Sandhoff K. Lysosomal degradation on vesicular membrane surfaces. Enhanced glucosylceramide degradation by lysosomal anionic lipids and activators. J Biol Chem 1998; 273:30271-30278.
185. Morimoto S, Martin BM, Kishimoto Y, O'Brien JS. Saposin D: a sphingomyelinase activator. Biochem Biophys Res Commun 1988; 156:403-410.
186. Tayama M, Soeda S, Kishimoto Y, Martin BM, Callahan JW, Hiraiwa M, O'Brien JS. Effect of saposins on acid sphingomyelinase. Biochem J 1993; 290(Pt 2):401-404.
187. Linke T, Wilkening G, Sadeghlar F, Mozcall H, Bernardo K, Schuchman E, SandhoffK. Interfacial regulation of acid ceramidase activity. Stimulation of ceramide degradation by lysosomal lipids and sphingolipid activator proteins. J Biol Chem 2001; 276: 5760-5768.
188. Ghadially R, Brown BE, Hanley K, Reed JT, Feingold KR, Elias PM. Decreased epidermal lipid synthesis accounts for altered barrier function in aged mice. J Invest Dermatol 1996; 106:1064-1069.
189. Rogers J, Harding C, Mayo A, Banks J, Rawlings A. Stratum corneum lipids: the effect of ageing and the seasons. Arch Dermatol Res 1996; 288:765-770.
190. Denda M, Koyama J, Hori J, Horii I, Takahashi M, Hara M, Tagami H. Age-dependent and sex-dependent change in stratum corneum sphingolipids. Arch Dermatol Res 1993; 285:415-417.
191. Lightle SA, Oakley JI, Nikolova-Karakashian MN. Activation of sphingolipid turnover and chronic generation of ceramide and sphingosine in liver during aging. Mech Ageing Dev 2000; 120:111-125.
192. Venable ME, Lee JY, Smyth MJ, Bielawska A, Obeid LM. Role of ceramide in cellular senescence. J Biol Chem 1995; 270:30701-30708.